greater export sales portion. 3. In Q3 2017, the Company and its subsidiaries recorded the assets’ impairment loss and write- off of Solvay Biochemicals (Taixing) Limited (“SBT”) net amounting to 132 MB
return loan from UOB Baht 12.00M., Credit term extension with vendors. The equity’s shareholder was lower than last year at 5.49% due operating loss this year. - In order to effectively manage the sales
) Sales 201 176 14 Total revenues 216 188 15 Cost of sales 181 164 11 Selling and administrative expenses 20 20 (3) Net profit (loss) 14 4 253 Sales Sales increased 25 million Baht or 14%, as a result of
Baht 0.88 million, decreasing by Baht 20.08 million when compared to that of Baht 20.96 million in the third quarter of the year 2016. 4. Net Profit (Loss) The operating profit of the Company and its
result, the Company recorded net Loss of 996 Million Baht. Pace Development Corporation Public Company Limited 87/2 CRC Tower All Seasons Place, 45th Floor, Unit 3, Wireless Road, Lumpini, Pathumwan
interest paid on loans from financial institutions). 3. Net profit attributable to parent companies for the three months as of November 30, 2017, divided to net loss from continuing operations the amount of
, the Company recorded net Loss of 962 Million Baht. Pace Development Corporation Public Company Limited 87/2 CRC Tower All Seasons Place, 45th Floor, Unit 3, Wireless Road, Lumpini, Pathumwan, Bangkok
million, mostly from profit sharing from investment in BBF decreased. Since crude palm oil price has declined, B100 price consequently declined and BBF had to realize an Inventory Loss. Decrease of
(44.6) (18.2) 26.5 (59.3) Non-Controlling Interests (685.0) (0.0) 685.0 (100.0) Profit attributable to Owners of the Parent 369.5 1,980.9 1,611.4 436.1 Foreign Exchange Gain (Loss) 6.2 574.3 568.2 9,224.6
46 (82) 883 n/a n/a 219 859 292% Net profit (loss) after NCI (40) (54) 654 n/a n/a 170 572 236% Performance without non-operating items 1 EBITDA 337 152 148 (3%) (56%) 797 753 (6%) 4Q17 % QoQ % YoY